Beijing Tong Ren Tang Chinese Medicine Company Limited (FRA:TQR)

Market Cap	793.70M -6.7%
Revenue (ttm)	185.36M +24.1%
Net Income	55.90M +4.3%
EPS	0.07 +4.3%
Shares Out	n/a
PE Ratio	14.20
Forward PE	13.66
Dividend	0.04 (4.18%)
Ex-Dividend Date	Jun 5, 2025

Volume	n/a
Average Volume	300
Open	0.9100
Previous Close	0.9350
Day's Range	0.9100 - 0.9100
52-Week Range	0.8950 - 1.0500
Beta	n/a
RSI	39.02
Earnings Date	Mar 13, 2026

About FRA:TQR

Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals. It operates through three segments: Hong Kong, Mainland China, and Overseas. The company offers Chinese medical consultation and treatment services. It also operates retail outlets in Hong Kong and in other countries and regions in Asia, Oceania, North America, and Europe. It markets its products under the Tong Ren Tang brand name. Be...

• Industry: Drug Stores and Proprietary Stores
• Founded: 1669
• Employees: 789
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: TQR

Financial Performance

In 2024, FRA:TQR's revenue was 1.61 billion, an increase of 5.69% compared to the previous year's 1.52 billion. Earnings were 500.28 million, a decrease of -7.42%.

Financial numbers in HKD